amlodipine has been researched along with Canine Diseases in 10 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this report is to document the case of a dog that developed pleural effusion as a potential side-effect to the administration of a high-dose of amlodipine." | 8.12 | Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension. ( An, JH; Chae, HK; Choi, M; Hwang, SY; Jang, HW; Kang, K; Oh, YI; Park, SM; Youn, HY, 2022) |
| " Supportive medical therapy was carried out and persistent systemic hypertension was managed using telmisartan." | 7.88 | Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine. ( Kang, SS; Kim, HJ; Kwon, YJ; Suh, GH, 2018) |
| "To describe the occurrence of systemic hypertension in dogs with acute kidney injury and the efficacy of amlodipine besylate for its treatment." | 7.77 | Occurrence of systemic hypertension in dogs with acute kidney injury and treatment with amlodipine besylate. ( Doherr, M; Francey, T; Geigy, CA; Schweighauser, A, 2011) |
| "Amlodipine therapy was discontinued and oedema diminished markedly within 72 hours." | 5.39 | Generalised peripheral oedema associated with amlodipine therapy in two dogs. ( Creevy, KE; Ellis, AE; Scuderi, MA, 2013) |
| "The aim of this report is to document the case of a dog that developed pleural effusion as a potential side-effect to the administration of a high-dose of amlodipine." | 4.12 | Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension. ( An, JH; Chae, HK; Choi, M; Hwang, SY; Jang, HW; Kang, K; Oh, YI; Park, SM; Youn, HY, 2022) |
| " Supportive medical therapy was carried out and persistent systemic hypertension was managed using telmisartan." | 3.88 | Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine. ( Kang, SS; Kim, HJ; Kwon, YJ; Suh, GH, 2018) |
| "To describe the occurrence of systemic hypertension in dogs with acute kidney injury and the efficacy of amlodipine besylate for its treatment." | 3.77 | Occurrence of systemic hypertension in dogs with acute kidney injury and treatment with amlodipine besylate. ( Doherr, M; Francey, T; Geigy, CA; Schweighauser, A, 2011) |
| "Amlodipine was the most common first-line agent (n=10), followed by hydralazine (n=4) and hypertonic saline (n=1)." | 1.72 | Evaluation of presentation, treatment and outcome in hypertensive emergency in dogs and cats: 15 cases (2003-2019). ( Beeston, D; Cortellini, S; Jepson, R, 2022) |
| "Arterial hypertension was treated with amlodipine but remained greater than the upper limit for 51 days until the dog recovered ambulation." | 1.56 | Acute idiopathic polyradiculoneuritis with secondary arterial hypertension in a 5-year-old male Siberian Husky. ( Baisan, AR; Henea, M; Hrițcu, LD; Mocanu, D; Musteata, M; Pașca, SA; Solcan, G; Ștefănescu, R, 2020) |
| "Ischemic optic neuropathy is a well-recognized cause of blindness in humans and should be included as a differential diagnosis for acute prechiasmatic blindness in dogs." | 1.48 | Ischemic Optic Neuropathy in a Dog with Acute Bilateral Blindness and Primary Systemic Hypertension. ( De Risio, L; Dominguez, E; Mari, L; Oliver, J; Premont, J; Stavinohova, R, 2018) |
| "Primary adrenocortical carcinomas developed in the dog met the definition of bilateral incidental adrenal gland masses (IAGMs)." | 1.46 | Clinical and pathological features and outcome of bilateral incidental adrenocortical carcinomas in a dog. ( Hasegawa, A; Itoh, H; Kishimoto, M; Murayama, H; Nabeta, R; Ogawa, M; Ohmori, K; Osada, H; Shibutani, M; Yoshida, T, 2017) |
| "Amlodipine therapy was discontinued and oedema diminished markedly within 72 hours." | 1.39 | Generalised peripheral oedema associated with amlodipine therapy in two dogs. ( Creevy, KE; Ellis, AE; Scuderi, MA, 2013) |
| "Systemic hypertension is one of the most common preexisting conditions." | 1.37 | Recurrent vestibular paroxysms associated with systemic hypertension in a dog. ( Bentley, RT; March, PA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, HW | 1 |
| Park, SM | 1 |
| Hwang, SY | 1 |
| Kang, K | 1 |
| Choi, M | 1 |
| An, JH | 1 |
| Chae, HK | 1 |
| Oh, YI | 1 |
| Youn, HY | 1 |
| Beeston, D | 1 |
| Jepson, R | 1 |
| Cortellini, S | 1 |
| Musteata, M | 1 |
| Ștefănescu, R | 1 |
| Baisan, AR | 1 |
| Mocanu, D | 1 |
| Pașca, SA | 1 |
| Hrițcu, LD | 1 |
| Henea, M | 1 |
| Solcan, G | 1 |
| Nabeta, R | 1 |
| Osada, H | 1 |
| Ogawa, M | 1 |
| Hasegawa, A | 1 |
| Kishimoto, M | 1 |
| Murayama, H | 1 |
| Yoshida, T | 1 |
| Shibutani, M | 1 |
| Itoh, H | 1 |
| Ohmori, K | 1 |
| Mari, L | 1 |
| Stavinohova, R | 1 |
| Dominguez, E | 1 |
| Premont, J | 1 |
| Oliver, J | 1 |
| De Risio, L | 1 |
| Kwon, YJ | 1 |
| Suh, GH | 1 |
| Kang, SS | 1 |
| Kim, HJ | 1 |
| Creevy, KE | 1 |
| Scuderi, MA | 1 |
| Ellis, AE | 1 |
| Kano, S | 1 |
| Ichihara, K | 1 |
| Komatsu, K | 1 |
| Satoh, K | 1 |
| Geigy, CA | 1 |
| Schweighauser, A | 1 |
| Doherr, M | 1 |
| Francey, T | 1 |
| Bentley, RT | 1 |
| March, PA | 1 |
10 other studies available for amlodipine and Canine Diseases
| Article | Year |
|---|---|
Unusual case of pleural effusion caused by amlodipine in a dog with systemic hypertension.
Topics: Acute Disease; Amlodipine; Animals; Dog Diseases; Dogs; Exudates and Transudates; Humans; Hypertensi | 2022 |
Evaluation of presentation, treatment and outcome in hypertensive emergency in dogs and cats: 15 cases (2003-2019).
Topics: Amlodipine; Animals; Antihypertensive Agents; Blindness; Cat Diseases; Cats; Dog Diseases; Dogs; Eme | 2022 |
Acute idiopathic polyradiculoneuritis with secondary arterial hypertension in a 5-year-old male Siberian Husky.
Topics: Amlodipine; Animals; Antihypertensive Agents; Dog Diseases; Dogs; Hypertension; Male; Polyradiculone | 2020 |
Clinical and pathological features and outcome of bilateral incidental adrenocortical carcinomas in a dog.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Amlodipine; Animals; Dog Diseases; Dogs; Female; | 2017 |
Ischemic Optic Neuropathy in a Dog with Acute Bilateral Blindness and Primary Systemic Hypertension.
Topics: Amlodipine; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blindness; Dog Diseases; Dog | 2018 |
Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.
Topics: Amlodipine; Animals; Antihypertensive Agents; Carcinoma, Renal Cell; Dog Diseases; Dogs; Hypertensio | 2018 |
Generalised peripheral oedema associated with amlodipine therapy in two dogs.
Topics: Amlodipine; Animals; Antihypertensive Agents; Dog Diseases; Dogs; Edema; Female; Hypertension | 2013 |
Comparative effects of azelnidipine and amlodipine on myocardial function and mortality after ischemia/reperfusion in dogs.
Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dog Disea | 2011 |
Occurrence of systemic hypertension in dogs with acute kidney injury and treatment with amlodipine besylate.
Topics: Acute Kidney Injury; Amlodipine; Animals; Antihypertensive Agents; Dog Diseases; Dogs; Female; Hyper | 2011 |
Recurrent vestibular paroxysms associated with systemic hypertension in a dog.
Topics: Amlodipine; Animals; Antihypertensive Agents; Ataxia; Dog Diseases; Dogs; Enalapril; Female; Hyperte | 2011 |